Juan Pablo Santino

Juan Pablo Santino

Auto-generated profile, based on publicly available information

Juan Pablo Santino

Servicio de Anatomía Patológica, Hospital Italiano de Buenos Aires

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Journal of Clinical Oncology
Verified
Journal Article
Open access
CSCarine El Sissy
Carine El Sissy
AKAmos Kirilovsky
Amos Kirilovsky
CPChristine Lagorce Pagès
Christine Lagorce Pagès
FMFlorence Marliot
Florence Marliot
PCPetra A. Custers
Petra A. Custers
FPFranck Pagès
Franck Pagès
PURPOSE: No biomarker capable of improving selection and monitoring of patients with rectal cancer managed by watch-and-wait (W&W) strategy is currently available. Prognostic performance of the Immunoscore biopsy (ISB) was recently suggested in a preliminary study. METHODS: This international validation study included 249 patients with clinical complete response (cCR) managed by W&W strategy. Intratumoral CD3+ and CD8+ T cells were quantified on pretreatment rectal biopsies by digital pathology and converted to ISB. The primary end point was time to recurrence (TTR; the time from the end of neoadjuvant treatment to the date of local regrowth or distant metastasis). Associations between ISB and outcomes were analyzed by stratified Cox regression adjusted for confounders. Immune status of tumor-draining lymph nodes (n = 161) of 17 additional patients treated by neoadjuvant chemoradiotherapy and surgery was investigated by 3'RNA-Seq and immunofluorescence. RESULTS: Recurrence-free rates at 5 years were 91.3% (82.4%-100.0%), 62.5% (53.2%-73.3%), and 53.1% (42.4%-66.5%) with ISB High, ISB Intermediate, and ISB Low, respectively (hazard ratio [HR; Low v High], 6.51; 95% CI, 1.99 to 21.28; log-rank P = .0004). ISB was also significantly associated with disease-free survival (log-rank P = .0002), and predicted both local regrowth and distant metastasis. In multivariate analysis, ISB was independent of patient age, sex, tumor location, cT stage (T, primary tumor; c, clinical), cN stage (N, regional lymph node; c, clinical), and was the strongest predictor for TTR (HR [ISB High v Low], 6.93; 95% CI, 2.08 to 23.15; P = .0017). The addition of ISB to a clinical-based model significantly improved the prediction of recurrence. Finally, B-cell proliferation and memory in draining lymph nodes was evidenced in the draining lymph nodes of patients with cCR. CONCLUSION: The ISB is validated as a biomarker to predict both local regrowth and distant metastasis, with a gradual scaling of the risk of pejorative outcome.

23 May 2023 in Radiologia
Verified
Journal Article
Closed access
FCF. Conca
F. Conca
NRN. Rosso
N. Rosso
RGR. López Grove
R. López Grove
LSL. Savluk
L. Savluk
JSJ.P. Santino
J.P. Santino
MUM. Ulla
M. Ulla

15 November 2024 in Familial Cancer
Verified
Journal Article
Closed access
PDF file
MGMaria Laura Gonzalez
Maria Laura Gonzalez
CVCarolina Vazquez
Carolina Vazquez
MAMaria J. Argüero
Maria J. Argüero
JSJuan P. Santino
Juan P. Santino
ABAna Braslavsky
Ana Braslavsky
MSMarcelo Martín Serra
Marcelo Martín Serra

13 December 2021 in Acta gastroenterológica latinoamericana
Verified
Journal Article
Open access
TPTomas Pérez
Tomas Pérez
RFRomina Lorena Alsina Farreta
Romina Lorena Alsina Farreta
MGMaría Laura González
María Laura González
APAnalía Verónica Pasqua
Analía Verónica Pasqua
MSMaría Josefina Sobrero
María Josefina Sobrero
MMMariano Martín Marcolongo
Mariano Martín Marcolongo
Endometriosis is defined as the presence of endometrial glands in extrauterine sites. Intestinal deep infiltrating endometriosis is considered when the endometriotic lesion is located more than 5 mm below the peritoneum. Intestinal obstruction due to endometriosis is rare, occurring in approximately 1% of cases. We present three cases with intestinal occlusion as deep infiltrating endometriosis debut. Its symptomatic presentation can mimic multiple gastroenterological entities, mainly irritable bowel syndrome or inflammatory bowel disease so its diagnosis can be difficult. However, suspecting this pathology and diagnosing it is important to define therapeutic behavior and improve the quality of life of our patients.

15 December 2018 in Oncología Clínica
Verified
Journal Article
Open access
PDF file
VKVanesa Kazanietz
Vanesa Kazanietz
JSJésica Storino
Jésica Storino
JSJuan Pablo Santino
Juan Pablo Santino
PMPablo Pérez Mesa
Pablo Pérez Mesa
FCFederico Cayol
Federico Cayol
El adenocarcinoma hepatoide gástrico es un tumor maligno de baja incidencia, se describen asociados a aumento de alfa-fetoproteína y tienen pobre pronóstico. Se presenta el caso de un paciente de 44 años que en un contexto de síndrome de impregnación se evidencian múltiples lesiones hepáticas asociadas al aumento de alfa-fetoproteína. El diagnóstico y el tratamiento de estos tumores representan un desafío para el equipo médico.

26 October 2022 in Oncología Clínica
Verified
Journal Article
Closed access
PDF file
MPMelina Pochettino
Melina Pochettino
JSJuan Pablo Santino
Juan Pablo Santino
FCFederico Cayol
Federico Cayol
Se presenta a continuación el caso clínico de una mujer de 69 años con diagnóstico de adenocarcinoma de la unión gastroesofágica localmente avanzado, que realizó tratamiento con esquema CROSS y posterior esofagectomía. Presentó recaída en un sitio poco frecuente, a nivel de la base de la lengua. Se realizó la caracterización molecular de la lesión que demostró pérdida de expresión de proteínas de reparación del ADN por mismatch.